175 related articles for article (PubMed ID: 23292866)
1. Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers.
Wan D; He S; Xie B; Xu G; Gu W; Shen C; Hu Y; Wang X; Zhi Q; Wang L
Med Oncol; 2013 Mar; 30(1):378. PubMed ID: 23292866
[TBL] [Abstract][Full Text] [Related]
2. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
4. A critical role of mir-199a in the cell biological behaviors of colorectal cancer.
Ye H; Pang L; Wu Q; Zhu Y; Guo C; Deng Y; Zheng X
Diagn Pathol; 2015 Jun; 10():65. PubMed ID: 26065676
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of miR-22 expression in patients with colorectal cancer.
Zhang G; Xia S; Tian H; Liu Z; Zhou T
Med Oncol; 2012 Dec; 29(5):3108-12. PubMed ID: 22492279
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of miR-1826 as a Novel Prognostic Biomarker in Colorectal Cancer.
Hu Y; Yi B; He S; Gao L; Liu P; Wang L; Yu J; Wan D; Zhou J; Zhu X; Zhi Q
Anticancer Agents Med Chem; 2016; 16(9):1109-16. PubMed ID: 25968874
[TBL] [Abstract][Full Text] [Related]
7. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
Li L; Mou YP; Wang YY; Wang HJ; Mou XZ
Pathol Res Pract; 2019 Sep; 215(9):152511. PubMed ID: 31255331
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
Tan HY; Zheng YB; Liu J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
11. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
13. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
Peng H; Pan X; Su Q; Zhu LS; Ma GD
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
[TBL] [Abstract][Full Text] [Related]
14. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.
Ye X; Lv H
Biomed Pharmacother; 2018 Sep; 105():879-886. PubMed ID: 30021381
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
18. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
19. MAGP2, a Component of Extracellular Matrix, Is Upregulated in Colorectal Cancer and Negatively Modulated by miR-200b-3p.
Feifei W; Hui G; Ruiqiang Z; Qunxiang J; Yu'an X
Technol Cancer Res Treat; 2019 Jan; 18():1533033819870777. PubMed ID: 31426719
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
